Manager, People Systems (Workday)
Recorded FutureSalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, PharmaceuticalIndustries
Requirements
Candidates should possess a Bachelor’s degree in Human Resources, Information Systems, or a related field, and ideally have some experience with HRIS systems. A strong interest in learning Workday and understanding HR processes is essential, along with the ability to troubleshoot technical issues and analyze data. Familiarity with ServiceNow and Power BI is a plus.
Responsibilities
The HRIS Specialist, People Systems will be responsible for supporting the Workday HR system, troubleshooting issues, analyzing production tickets, maintaining system data, and providing day-to-day support for HR systems. They will also learn and support Workday business processes, assist with creating content for the employee portal, collaborate with IT and the Programs and Analytics team, respond to tickets in ServiceNow, create reports for the HR team, and support annual HR cycle activities. Furthermore, they will be responsible for providing training and support to Workday users and assisting with configuration support for Core HCM, Security, Benefits, and Recruiting modules.
Skills
Workday
HRIS
HCM
HR Systems
Data Analysis
Problem Solving
Troubleshooting
Data Entry
HR Processes
Axsome Therapeutics Inc
Develops therapies for CNS disorders
About Axsome Therapeutics Inc
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.
Key Metrics
New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees